Research published by Cass Business School provides new evidence on the strong performance of private equity-backed IPOs.
The report was commissioned jointly by the British Private Equity and Venture Capital Association and the London Stock Exchange, and covers the period January 1995 to December 2006. Key findings include:
private equity-backed IPOs outperform other IPOs by more than 9% one year after their public listing
they also outperform the FTSE ALL Share Index by 20% over the same period
venture capital-backed IPOs typically spend up to five times as much on R&D as their non private equity-backed counterparts at the time of flotation
typical private equity-backed IPOs spend twice as much on capital expenditure in relation to total assets as non private equity-backed companies.
Commenting on these findings, Simon Walker, Chief Executive of the BVCA, said:
‘This research provides more evidence of the way in which private equity is good at building better businesses by growing value. The figures on spending on R&D and capital investment underline the big contribution that private equity and venture capital make to creating both businesses and an economy that are more innovative.’
The report also shows that:
private equity-backed IPOs account for more than 50% of the total number of companies in the consumer services, industrials, healthcare and technology sectors in the Main market.The majority of venture capital-backed IPOs are in the health and technology sectors out of 1,735 IPOs on the London Stock Exchange Main and AIM markets between 1995 and 2006, private equity-backed IPOs accounted for 22% of the number of IPOs and 27% – or £18.9 billion – of the total sum raised the average length of time a private equity firm invests in a company before flotation is 4.5 years for venture-capital-backed IPOs and 3.8 years for PE-backed IPOs
IPOs in the Main market perform relatively better than their AIM counterparts the PE firm typically holds an average of 33.2% in venture capital-backed IPOs and 59.2% in PE-backed IPOs just before flotation. Immediately after flotation, these holdings are at 19.8% and 28.5% respectively, showing the continuing involvement that the original investors have in the business.
Professor Mario Levis, author of the Report, said:
‘The study shows significant aftermarket performance for private equity-backed IPOs. Such IPOs are more profitable, they are run more efficiently and they invest more in both physical assets and R&D than their non-private equity backed-counterparts. Investors will increasingly look for such attributes in companies seeking a public listing under the challenging current market conditions.’
Nick Langford, Head of UK Business Development for Equity Primary Markets at the London Stock Exchange, said:
‘These findings underline the importance of the complementary relationship between private equity and venture capital and our markets. In particular, the success of AIM has provided a choice of exit routes catering to companies of different sizes and sectors and at different stages in their development.’
Dimitra Koutsantoni | alfa
Europe's microtechnology industry is attuned to growth
10.03.2017 | IVAM Fachverband für Mikrotechnik
Preferential trade agreements enhance global trade at the expense of its resilience
17.02.2017 | International Institute for Applied Systems Analysis (IIASA)
The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.
To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
28.03.2017 | Physics and Astronomy
28.03.2017 | Health and Medicine
28.03.2017 | Life Sciences